Responsible for developing and driving the company’s sales strategy across Europe, the appointment serves as the next significant commercial team investment for Clasado.
The business has continued to extend its reach with the recent launch of Bimuno to the North American market through distribution partner STAUBER.
Clasado now turns its focus to the burgeoning European nutraceutical market, forecast to see a compound annual growth rate of 7.5% until 2025, according to intelligence agency Mordor.
Per Rehné, CEO at Clasado, commented: “We are delighted to welcome Gareth to the Clasado team. The business has made real strides in recent months as our patented prebiotic Bimuno finds new applications in supplements and functional foods.
“What’s crucial to us is that we don’t just offer an effective science-backed ingredient to the market, but in doing so actively contribute to global gut health awareness."
"With almost 20 years in the food and nutrition sector and expertise in turning raw data and insight into commercial value, Gareth is perfectly positioned to help us achieve this, and a great match for the team."
